Your browser doesn't support javascript.
loading
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer.
Pabst, Lucile; Lopes, Sébastien; Bertrand, Basil; Creusot, Quentin; Kotovskaya, Maria; Pencreach, Erwan; Beau-Faller, Michèle; Mascaux, Céline.
Afiliação
  • Pabst L; Pulmonology Department, University Hospital of Strasbourg, 67000 Strasbourg, France.
  • Lopes S; Pharmacy Department, University Hospital of Strasbourg, 67000 Strasbourg, France.
  • Bertrand B; Pulmonology Department, University Hospital of Strasbourg, 67000 Strasbourg, France.
  • Creusot Q; Laboratory Streinth (STress REsponse and INnovative THerapy against Cancer), Inserm UMR_S 1113, IRFAC, Université de Strasbourg, ITI InnoVec, 67000 Strasbourg, France.
  • Kotovskaya M; Pulmonology Department, University Hospital of Strasbourg, 67000 Strasbourg, France.
  • Pencreach E; Laboratory Streinth (STress REsponse and INnovative THerapy against Cancer), Inserm UMR_S 1113, IRFAC, Université de Strasbourg, ITI InnoVec, 67000 Strasbourg, France.
  • Beau-Faller M; Pulmonology Department, University Hospital of Strasbourg, 67000 Strasbourg, France.
  • Mascaux C; Laboratory Streinth (STress REsponse and INnovative THerapy against Cancer), Inserm UMR_S 1113, IRFAC, Université de Strasbourg, ITI InnoVec, 67000 Strasbourg, France.
Int J Mol Sci ; 24(8)2023 Apr 20.
Article em En | MEDLINE | ID: mdl-37108738
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article